Skip to content

NRL Pharma, Inc. (Japan)

NRL Pharma, Inc. is an emerging specialty pharmaceutical and food company committed to supply enteric lactoferrin, 'PEG-lactoferrin,' and ascochlorin derivatives.

Last updated September 1, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

NRL Pharma, Inc. is a drug discovery venture company based in Shinagawa, Tokyo, Japan. Its corporate philosophy is to deliver health to all people through improving QOL, not only to patients but also to pre-symptomatic and healthy individuals. The company focuses on lactoferrin, a multifunctional protein, and develops health foods, cosmetics, and drugs.

History

NRL Pharma, Inc. was established on April 23, 1998. The company is headquartered at 11F Gotenyama Trust Tower, 4-7-35 Kitashinagawa, Shinagawa-ku, Tokyo. Its capital is 64 million yen. The company's line of business includes research, development, manufacturing and sales of health foods and food materials such as Lactoferrin, cosmetics, and drugs & quasi-drugs.

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/nrl-pharma-inc-japan · Editorial policy · How profiles are compiled